217 results on '"Naber, K G"'
Search Results
2. Linguistic validation and cognitive assessment of the French version of the Acute Cystitis Symptom Score questionnaire
3. Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany
4. Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men
5. Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men
6. Prostatitis: the role of antibiotic treatment
7. Ciprofloxacin 250 mg Twice Daily Versus Ofloxacin 200 mg Twice Daily in the Treatment of Complicated Urinary Tract Infections in Women
8. Urinary Excretion and Bactericidal Activity of Intravenous Ciprofloxacin Compared with Oral Ciprofloxacin
9. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose
10. Therapeutic challenges of urosepsis
11. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status
12. Serum and Prostatic Tissue Concentrations of Moxifloxacin (400 mg) after a Single Intravenous Infusion in Patients with Benign Prostatic Hyperplasia Undergoing Transurethral Resection of the Prostate: ABS/PP-01/ACUBali/01-B
13. Current challenges in the treatment of complicated urinary tract infections and prostatitis
14. Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients
15. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women
16. Bacterial spectrum and antibiotic resistance of uropathogens in hospitalised urological patients with urinary tract infections (1994–2004) and consequences for the empiric antibiotic therapy: P1877
17. Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/Co-trimoxazole
18. Pharmacokinetics of Temafloxacin in Patients with Liver Impairment
19. Characteristics of patients with urinary tract infections
20. Concentrations in plasma and urinary excretion of ciprofloxacin XR (1000 mg) vs. levofloxacin (500 mg) in healthy volunteers receiving a single oral dose
21. The role of quinolones in the treatment of chronic bacterial prostatitis
22. Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue
23. Abdominal actinomycosis
24. Antimicrobial treatment of prostatitis
25. In vitro activity of daptomycin against Gram-positive uropathogens
26. Symposium: Detection and management of lower UTIs — The value of single dose therapy. Munich, 19 November 1988
27. Fosfomycin trometamol versus ofloxacin/Co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: A multicentre study
28. Prostatitis
29. Urine sampling method and significance of bacteriuria in men
30. Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid
31. Fosfomycin trometamol in treatment of uncomplicated lower urinary tract infections in adult women — An overview
32. Proposed study design in prostatitis
33. Summary
34. Closing remarks
35. Introductory remarks
36. Closing remarks: VII Sils Maria Symposium 1990
37. Enoxacin-Konzentrationen in der Samenflüssigkeit, im Prostatasekret und im Prostataadenomgewebe nach oraler Gabe oder intravenöser Infusion
38. Renal lymph concentrations of cephalosporins: The importance of protein binding and renal excretion
39. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections
40. Renal function in chronic hydronephrosis with and without infection and the role of the lymphatics. An experimental study in dogs
41. Co-trimazine distribution in the canine prostate
42. Renal lymph and interstitial fluid concentration of co-trimazine: An experimental study in dogs
43. In Vitro Activity and Concentrations in Serum, Urine, Prostatic Secretion and Adenoma Tissue of Ofloxacin in Urological Patients
44. Cefotaxime in urinary tract infections
45. Activity of cefroxadine and cephalexin in urinary tract infections: A double-blind comparative study
46. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections
47. Various methods of determining irrigating fluid absorption during transurethal resection of the prostate: Theoretical and practical considerations
48. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function
49. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)
50. Single-dose therapy of uncomplicated urinary tract infections in females — treatment of choice?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.